A Gift from (and for) the Heart

United Therapeutics Corporation gives to establish an endowed professorship in pulmonary vascular disease.
United Therapeutics Corporation has given a generous gift to establish an endowed professorship in the UAB Division of Cardiovascular Disease. The United Therapeutics Endowed Professorship in Pulmonary Vascular Disease will assist UAB in recruiting a senior scientist to further expand the university’s research efforts in pulmonary hypertension and related conditions.

Sumanth D. Prabhu, M.D., director of the Division of Cardiovascular Disease, says the endowed professorship will help streamline the division’s efforts to develop therapies that help patients live longer, healthier lives. “The pulmonary hypertension program in the UAB Division of Cardiovascular Disease has been at the national forefront for many years,” he says. “This endowed professorship will allow us to bring a leader here that can integrate clinical and research efforts related to pulmonary hypertension across disciplines (bringing together cardiology, pulmonary, vascular biology, immunology, and lung transplantation, for example) that will ultimately provide the greatest benefit to our patients afflicted with the disease. We are deeply grateful to United Therapeutics Corporation for establishing this endowed professorship.”
    
According to Robert C. Bourge, M.D., a specialist in pulmonary hypertension in the Division of Cardiovascular Disease, “the UAB Pulmonary Vascular Disease Clinic was formed in 1986—the first in the southeastern United States—and remains one of the largest such clinics in the world. The United Therapeutics Endowed Professorship, made possible through a gift from a great friend of our program, will allow us to continue to grow our very important research program in pulmonary arterial hypertension and improve the quality of life and life span of our patients.”
    
Founded in 1996 by its chairman and chief executive officer, Martine A. Rothblatt, Ph.D., United Therapeutics Corporation has been a leader in the development of unique analogs of natural molecules for cardiopulmonary disorders, novel monoclonal antibodies for certain cancers, small glycobiologicals for infectious diseases, and telemedical services for astronauts on the International Space Station.

For more information about giving to the School of Medicine, visit www.uab.edu/medicine.